Chun Gwon Park
Overview
Explore the profile of Chun Gwon Park including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
1952
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee Y, Lee Y, Park J, Maksakova A, Seo D, Kim J, et al.
Biomed Pharmacother
. 2025 Jan;
183:117810.
PMID: 39799037
No abstract available.
2.
Park J, Shin H, An Y, Jang H, Park J, Kim S, et al.
Ann Lab Med
. 2025 Jan;
45(2):146-159.
PMID: 39774132
Natural killer (NK) cells are pivotal innate immune system components that exhibit spontaneous cytolytic activity against abnormal cells, such as infected and tumor cells. NK cells have shown significant promise...
3.
Lee Y, Lee Y, Park J, Maksakova A, Seo D, Kim J, et al.
Biomed Pharmacother
. 2024 Dec;
182():117795.
PMID: 39740390
The impairment of the p53 pathway was once regarded as inadequately druggable due to the specificity of the p53 structure, its flat surface lacking an ideal drug-binding site, and the...
4.
Kim J, Rhim W, Lee S, Park J, Song D, Cha S, et al.
ACS Nano
. 2024 Dec;
18(50):33937-33952.
PMID: 39648484
Extracellular vesicles (EVs) possess the characteristics of their parent cells, based on which various studies have actively investigated treatments for diseases using mesenchymal stem cell-derived EVs due to their regenerative...
5.
Kim H, Koo K, Kim C, Byun M, Park C, Son H, et al.
Nano Converg
. 2024 Nov;
11(1):44.
PMID: 39482392
The challenges associated with animal testing in pharmaceutical development have driven the search for alternative in vitro models that mimic human tissues more accurately. In this study, we present a...
6.
Park N, Kim K, Park C, Jung H, Park W, Na K
J Control Release
. 2024 Aug;
374:384-399.
PMID: 39173953
Stem cell-based therapies offer promising avenues for treating inflammatory diseases owing to their immunomodulatory properties. However, challenges persist regarding their survival and efficacy in inflamed tissues. Our study introduces a...
7.
Shin H, Han J, Shin S, Bae G, Son B, Kim T, et al.
Acta Pharm Sin B
. 2024 Jul;
14(7):3169-3183.
PMID: 39027257
Optimum genetic delivery for modulating target genes to diseased tissue is a major obstacle for profitable gene therapy. Lipid nanoparticles (LNPs), considered a prospective vehicle for nucleic acid delivery, have...
8.
Lee D, Oh S, Lee D, Woo H, Ahn J, Kim S, et al.
Adv Sci (Weinh)
. 2024 Jul;
11(33):e2403463.
PMID: 38962927
In this study, a novel synthesis of ultrathin, highly uniform colloidal bismuth sulfohalide (BiSX where X = Cl, Br, I) nanowires (NWs) and NW bundles (NBs) for room-temperature and solution-processed...
9.
Kim J, Lee S, Cha S, Park J, Song D, Lee S, et al.
Int J Mol Sci
. 2024 May;
25(10).
PMID: 38791285
Extracellular vesicles (EVs) have been found to have the characteristics of their parent cells. Based on the characteristics of these EVs, various studies on disease treatment using mesenchymal stem cell...
10.
Choi J, Kim K, Mukhambetiyar K, Lee N, Sabate Del Rio J, Joo J, et al.
ACS Nano
. 2024 May;
18(22):14388-14402.
PMID: 38775287
Organ-on-a-chip, which recapitulates the dynamics of vasculature, has emerged as a promising platform for studying organ-specific vascular beds. However, its practical advantages in identifying vascular-targeted drug delivery systems (DDS) over...